Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Gracell to Start China Trial of CAR-T in Leukemia Patients

EdiGene Approved to Start China Trial of Gene-Edited Stem Cell Therapy

Gracell to Start China Trial of Donor-derived CAR-T Therapy for B-ALL

Everest to Start China Phase III Trial of ADC For Urothelial Cancer

InnoCare Approved to Launch BTK Inhibitor for Three Indications in China

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China